Compare Motilal Oswal Nifty MidSmall Healthcare Index Fund vs UTI Healthcare Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
1.12
2.28
NAV
₹10.37
₹269.31
Fund Started
29 Oct 2024
01 Aug 2005
Fund Size
₹29.42 Cr
₹1101.63 Cr
Exit Load
Exit load of 1%, if redeemed within 15 days.
Exit load of 1% if redeemed within 30 days.
1 Year
-1.01%
-3.06%
3 Year
-
22.21%
5 Year
-
13.89%
Equity
99.84%
99.40%
Cash
0.16%
0.59%
Top 10 Holdings
Lupin Ltd. | 9.33% |
Fortis Healthcare Ltd. | 8.87% |
Laurus Labs Ltd. | 7.43% |
Aurobindo Pharma Ltd. | 6.36% |
Alkem Laboratories Ltd. | 5.94% |
Glenmark Pharmaceuticals Ltd. | 5.43% |
Mankind Pharma Ltd. | 4.72% |
Biocon Ltd. | 4.44% |
Ipca Laboratories Ltd. | 3.75% |
Krishna Institute of Medical Sciences Ltd | 3.13% |
Sun Pharmaceutical Industries Ltd. | 9.37% |
Ajanta Pharma Ltd. | 7.16% |
Lupin Ltd. | 5.65% |
Glenmark Pharmaceuticals Ltd. | 4.06% |
Gland Pharma Ltd. | 3.60% |
Procter & Gamble Health Ltd. | 3.46% |
Dr. Reddy's Laboratories Ltd. | 3.46% |
Cipla Ltd. | 3.43% |
Alkem Laboratories Ltd. | 3.40% |
Apollo Hospitals Enterprise Ltd. | 3.39% |
Name
Swapnil P Mayekar
-
Start Date
18 Nov 2025
-
Description
The scheme seeks to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty MidSmall Healthcare Total Return Index, subject to tracking error.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
29 Oct 2024
01 Aug 2005